neurocare.
- Founded date 2015
- Investment year 2022
- Transaction value 50k
- Shares held
NeuroCareGroup’s proprietary e-platform—Digital Therapy Platform—integrates advanced processes and technologies, including solutions that utilize artificial intelligence, brain mapping, and sleep analysis in patient treatment. These modern methods assist doctors in making accurate diagnostic decisions and ultimately in developing comprehensive and personalized therapy plans. This approach helps alleviate the progression of mental health disorders and improves patients’ cognitive function. The company supports clinical practice in many countries, integrating AI solutions with precise identification of the underlying causes of patients’ conditions, leveraging both neuroscience and the latest advancements in psychedelic therapy.
neurocare
Envoy America
Since 2015, Envoy Has Been Addressing The Social Determinants Of Health Including Isolation, Loneliness And Disengagement By Offering Spectacular Customer Service.
Envoy excels beyond the industry standard for customer service. Envoy consistently ranks 99% for its on-time performance, engineering each service to exceed all expectations & improve quality of life.
From medical appointments, to grocery shopping, religious services, sporting events, theater, cultural events, family get togethers, walk their pet and help with technology – whatever they desire, Envoy America is going to drive better.
